Sue Dooley | Head of Investor Relations |
Ido Schoenberg | Chairman & Co-Chief Executive Officer |
Bob Shepardson | Chief Financial Officer |
Charles Rhyee | Cowen |
Eric Percher | Nephron Research |
Jessica Tassan | Piper Sandler |
Good evening. My name is Rex, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amwell 2Q 2022 Earnings Conference Call. All lines have been placed on you to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.